Cytokine release syndrome in severe COVID-19

Science. 2020 May 1;368(6490):473-474. doi: 10.1126/science.abb8925. Epub 2020 Apr 17.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Betacoronavirus
  • C-Reactive Protein / analysis
  • COVID-19
  • Coronavirus Infections / pathology*
  • Cytokine Release Syndrome / etiology*
  • Humans
  • Immunotherapy, Adoptive
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-6 / blood
  • Lymphohistiocytosis, Hemophagocytic / etiology
  • Pandemics
  • Pneumonia, Viral / pathology*
  • Receptors, Chimeric Antigen
  • Respiratory Distress Syndrome / etiology
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • IL6 protein, human
  • Interleukin-6
  • Receptors, Chimeric Antigen
  • C-Reactive Protein
  • tocilizumab